Healthy Extracts (HYEX) Total Current Liabilities (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Total Current Liabilities came in at $1.7 million in Q4 2025, up 26.01% year-on-year from $1.3 million in Q4 2024, and up 43.83% quarter-over-quarter from $1.2 million in Q3 2025.
Healthy Extracts (HYEX) Total Current Liabilities (2015 - 2025) Analysis & Trends
Healthy Extracts' Total Current Liabilities history runs 11 years deep, the most recent figure standing at $1.7 million for Q4 2025.
- On a quarterly basis, Total Current Liabilities rose 26.01% year-over-year to $1.7 million in Q4 2025; TTM through Dec 2025 was $1.7 million, a 26.01% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 26.01% from the prior year.
- Total Current Liabilities rose to $1.7 million in Q4 2025 per HYEX's latest filing, from $1.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $2.5 million in Q1 2024 and bottomed at $503826.0 in Q1 2022.
- The 5-year median for Total Current Liabilities is $1.5 million (2023), against an average of $1.5 million.
- Biggest YoY gain for Total Current Liabilities was 1870.47% in 2021; the steepest drop was 65.43% in 2021.
- Year by year, Total Current Liabilities stood at $558841.0 in 2021, then jumped by 61.55% to $902788.0 in 2022, then jumped by 86.14% to $1.7 million in 2023, then decreased by 20.27% to $1.3 million in 2024, then climbed by 26.01% to $1.7 million in 2025.
- Per Business Quant, the three latest HYEX Total Current Liabilities figures stand at $1.7 million (Q4 2025), $1.2 million (Q3 2025), and $861802.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | 1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.69 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 861,802.00 |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | 2.45 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 1.48 Mn |
| Mar 31, 2023 | 1.51 Mn |
| Dec 31, 2022 | 902,788.00 |
| Sep 30, 2022 | 944,248.00 |
| Jun 30, 2022 | 896,208.00 |
| Mar 31, 2022 | 503,826.00 |
| Dec 31, 2021 | 558,841.00 |
| Sep 30, 2021 | 2.45 Mn |
| Jun 30, 2021 | 2.04 Mn |
| Mar 31, 2021 | 1.33 Mn |